학술논문

Molecular Targeting of RRM2, NF-kappa B, and Mutant TP53 for the Treatment of Triple-Negative Breast Cancer
Document Type
Journal
Source
MOLECULAR CANCER THERAPEUTICS; APR 1 2021, 20 4, p655-p664, 10p.
Subject
Language
English
ISSN
15388514